State of Alaska
                                                          Fiscal Note
                                                                                        Bill Version:                    SB 198
 2018 Legislative Session
                                                                                        Fiscal Note Number:              1
                                                                                        (S) Publish Date:                4/4/2018
 Identifier:       SB198-UA-AC-3-27-18                                    Department:       University of Alaska
 Title:            UAA LONG-ACTING CONTRACEPTION STUDY                    Appropriation: University of Alaska
 Sponsor:          KELLY                                                  Allocation:       Anchorage Campus
 Requester: Senate Finance                                                OMB Component Number:              753
 Expenditures/Revenues
 Note: Amounts do not include inflation unless otherwise noted below.                                                          (Thousands of Dollars)
                                                 Included in
                                    FY2019       Governor's
                                Appropriation      FY2019                                      Out-Year Cost Estimates
                                  Requested       Request
 OPERATING EXPENDITURES               FY 2019        FY 2019       FY 2020                FY 2021           FY 2022            FY 2023         FY 2024
 Personal Services                        93.1                        103.9                   98.1
 Travel
 Services                                 30.0                         60.0                   60.0
 Commodities                              25.0                         25.0                    5.0
 Capital Outlay
 Grants & Benefits
 Miscellaneous
 Total Operating                         148.1            0.0         188.9                  163.1                 0.0              0.0              0.0
 Fund Source (Operating Only)
 1004 Gen Fund (UGF)                              148.1                   188.9              163.1
 Total                                            148.1      0.0          188.9              163.1                 0.0              0.0              0.0
 Positions
 Full-time
 Part-time
 Temporary
 Change in Revenues
 None
 Total                                              0.0      0.0             0.0                0.0                0.0              0.0              0.0
 Estimated SUPPLEMENTAL (FY2018) cost:            0.0               (separate supplemental appropriation required)
 (discuss reasons and fund source(s) in analysis section)
 Estimated CAPITAL (FY2019) cost:                 0.0               (separate capital appropriation required)
 (discuss reasons and fund source(s) in analysis section)
 ASSOCIATED REGULATIONS
 Does the bill direct, or will the bill result in, regulation changes adopted by your agency?
 If yes, by what date are the regulations to be adopted, amended or repealed?
 Why this fiscal note differs from previous version/comments:
 This new version of the Fiscal Note makes two changes: 1) it removes revenues, which were incorrectly included in the original version.
 The bill itself will not result in a change of revenues to UA and 2) changes the fund source to 1004 General Funds. The original version
 incorrectly listed the fund source as 1037 GF/Mental Health.
 Prepared By:              Michelle Rizk                                                                     Phone:          (907)322-9625
 Division:                 University of Alaska
                                                              REPORT                                         Date:           03/26/2018 02:30 PM
                                                                            ED
                                                               SFC 04/0 OUT OF
 Approved By:              Michelle Rizk                                                                     Date:           03/26/18
 Agency:                   University of Alaska
                                                                             4/2018
Printed 4/4/2018                                                Page 1 of 2                                                           Control Code: tDXtU
                                                                                                                 SB 198 - Fiscal Note 1
                                                 FISCAL NOTE ANALYSIS
STATE OF ALASKA                                                                  BILL NO. SB198
2018 LEGISLATIVE SESSION
Analysis
     Through SB 198, the University of Alaska Anchorage Center for Alcohol and Addiction Studies will conduct a study to
     evaluate the feasibility and effectiveness of providing Long Acting Reversible Contraception (LARC) to women with
     substance abuse disorders who are at high risk for unintended pregnancies that may result in prenatal drug or alcohol
     exposure. The study will be done in collaboration with hospitals and health care providers in Alaska who treat women with
     substance abuse disorders.
     Project Outcomes:
      Establish a collaborative network of service providers treating women at high risk of Neonatal Abstinence Syndrome
        (NAS) and/or Fetal Alcohol Spectrum Disorders (FASD)
      Assess the feasibility and utility of providing LARCs to the Neonatal Abstinence Evaluation Support Treatment (NEST)
        program
      Develop a cohort of women and children receiving NEST services for long term followup
      Provide a datadriven framework and foundation for a comprehensive LARC strategy in Alaska
      Provide a full report to the Alaska State Legislature and Key Stakeholders
     The study will begin in July 2018 and be conducted in three phases:
     Phase 1: Development (July 2018  March 2019)
                    Establish and convene advisory panels, develop clinical protocols, research procedures
     Phase 2: Implementation and Evaluation (March 2019  May 2020)
                    Implement referral protocols, assemble cohort, data collection, network collaboration
     Phase 3: Data Analysis and Reporting (April 2019  June 2021)
                    Data analysis, strategy development, outcomes, reporting, strategy recommendations
     Funding covers personnel costs for time contributed by principal investigator and coinvestigators; contracted case
     management, and medical commodities necessary for the study to include the cost of providing contraception to project
     participants without health insurance.
     Two interim reports will be provided: June 30, 2019 and June 30, 2020, and a final report will be due by June 30, 2021.
(Revised 9/26/17 OMB/LFD)                                                                                          Page 2 of 2
SB198-UA-AC-3-27-18                                            Page 2 of 2                                              Control Code: tDXtU